Dr. Karam Paul Asmaro, MD

Dr. Asmaro practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Asmaro's NPI, 1659799138, was assigned on April 2, 2014. Dr. Asmaro graduated from Wayne State University School Of Medicine in 2014. Dr. Asmaro holds Michigan license 4301501939.

Dr. Asmaro's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Asmaro's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Asmaro is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Michigan Healthcare Professionals, P.C. Dmand AI also links Dr. Asmaro to 3 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Asmaro practices, 8 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Asmaro's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Asmaro is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Asmaro's licenses on file in 3 states: Michigan, California and Ohio.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Asmaro treats.

CMS data shows 129 Medicare services from Dr. Asmaro across 5 procedure codes in 2024, all of them office visits, for 138 Medicare patients. Medicare paid $10,331 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Asmaro in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Asmaro's median patient age at 62, with 55% women.

In 2024, Dr. Asmaro wrote 76 Medicare Part D claims for 33 patients. 99% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $147 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dr. Asmaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Asmaro as offering telehealth. CMS counts 254 procedures of spinal fusion by Dr. Asmaro, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 39 papers to Dr. Asmaro, published from 2011 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Brain, DNA Methylation and Ischemic Preconditioning. Dr. Asmaro has published most often in Neurosurgery. Dr. Asmaro's most frequent co-authors are Steven N. Kalkanis, MD, Jack P. Rock, MD and Tobias Walbert, MD, PhD.

CMS Open Payments shows 69 general payments to Dr. Asmaro from 19 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 46% of the total. Kuros Biosciences USA, Inc paid the most, $7,727.

Dmand AI lists 8 awards for Dr. Asmaro, most recently Nominated for The Oustanding Resident Award in 2021.

Dr. Asmaro graduated from Wayne State University School Of Medicine in 2014. Dr. Asmaro is a member of AOA, AANS, CNS and NASBS.

Dr. Asmaro is in network with 18 carriers, including Aetna, Elevance and Health Alliance Plan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.